OCULOXIN® is a unique blend of standardized extracts from Vaccinium myrtillus L., Aronia Melanocarpa, and Lonicera caerulea var. Kamtschatica, designed to enhance visual health. This innovative formula features a synergistic mix of polyphenols, including anthocyanins, and iridoids, optimized to improve various visual parameters. Sourced from local, controlled plantations in Poland, OCULOXIN® guarantees high-quality extracts. The production involves double standardization, ensuring anthocyanins content of at least 25% and iridoids of no less than 2%. Recommended for those experiencing eye strain from screens, presbyopia, early diabetic retinopathy, or asthenopia, the suggested dose is 150-200 mg twice daily.
Home » OCULOXIN®: A Synergistic Blend for Enhanced Visual Health
OCULOXIN®: A Synergistic Blend for Enhanced Visual Health
Facebook
Twitter
LinkedIn
Email
WhatsApp
Facebook
Twitter
LinkedIn
Email
WhatsApp
Related Shorts
Ageing Alters Oral Microbiome in Women, Pilot Study Suggests
April 24, 2026
HIIT + Vitamin D Improves Bone Density in Osteoporosis
April 24, 2026